Gastric Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Feb 1, 2004; 10(3): 352-355
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.352
Figure 1
Figure 1 Semi-quantitative RT-PCR amplified products of VEGF-C and FLT-4 in primary gastric cancer and adjacent nor-mal tissues. Lane-M: puc mix marker 8 (1116, 883, 692, 501, 404, 331, 242, 190, 147, 110, 67, 34, 26, 19) bp, 644 bp: internal standards, 298 bp: FLT-4 expression, 206 bp: VEGF-C expression, Lane 1: Control of VEGF-C positive expression in placenta, Lane 6: Control of FLT-4 positive expression in placenta, Lanes 2, 4: VEGF-C expression in primary gastric cancer, Lanes 3, 5: VEGF-C expression in adjacent normal tissues, Lanes 7, 9: FLT-4 expression in primary gastric cancer, Lanes 8, 10: FLT-4 expression in adjacent normal tissues.
Figure 2
Figure 2 Expression of VEGF-C and FLT-4 in gastric cancer. A: VEGF-C positive expression in gastric cancer, × 400. B: FLT-4 positive expression in gastric cancer, × 200. (←endothelial cells of vessels).